The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease

BACKGROUND: Strict glycaemic control in patients with type 2 diabetes has proven to have microvascular benefits while the effects on CVD and mortality are less clear, especially in high risk patients. Whether strict glycaemic control would reduce the risk of future CVD or mortality in patients with...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cardiovasc Diabetol
Huvudupphovsmän: Bots, Sophie H., van der Graaf, Yolanda, Nathoe, Hendrik M. W., de Borst, Gert Jan, Kappelle, Jaap L., Visseren, Frank L. J., Westerink, Jan
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Original Investigation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950600/
https://ncbi.nlm.nih.gov/pubmed/27431507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0418-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk